NCT02584647: A trial that was reported late by Gulam Manji
This trial has reported, although it was 195 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02584647 |
|---|---|
| Title | Phase I Study Evaluating Combination Therapy With the Receptor Tyrosine Kinase Inhibitor PLX3397 and Sirolimus in Patients With Unresectable Sarcoma and Phase II Study in Malignant Peripheral Nerve Sheath Tumors |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 4, 2015 |
| Completion date | July 31, 2023 |
| Required reporting date | July 30, 2024, midnight |
| Actual reporting date | Feb. 11, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 195 |